Wall Street analysts expect Celanese Co. (NYSE:CE) to report earnings of $2.50 per share for the current quarter, Zacks reports. Three analysts have issued estimates for Celanese’s earnings. The highest EPS estimate is $2.70 and the lowest is $2.42. Celanese posted earnings of $2.62 per share in the same quarter last year, which would suggest a negative year over year growth rate of 4.6%. The firm is expected to announce its next quarterly earnings report on Monday, April 27th.
On average, analysts expect that Celanese will report full-year earnings of $10.80 per share for the current year, with EPS estimates ranging from $10.50 to $11.30. For the next fiscal year, analysts forecast that the company will report earnings of $11.93 per share, with EPS estimates ranging from $11.06 to $13.40. Zacks’ EPS calculations are an average based on a survey of analysts that that provide coverage for Celanese.
Celanese (NYSE:CE) last posted its quarterly earnings results on Thursday, January 30th. The basic materials company reported $1.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.09 by ($0.10). Celanese had a net margin of 13.53% and a return on equity of 37.36%. The business had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.52 billion. During the same period in the previous year, the business posted $2.38 EPS. The business’s revenue for the quarter was down 15.2% compared to the same quarter last year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in CE. Ladenburg Thalmann Financial Services Inc. raised its stake in shares of Celanese by 7.9% during the 2nd quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,112 shares of the basic materials company’s stock worth $337,000 after purchasing an additional 228 shares during the period. BlackRock Inc. raised its stake in Celanese by 0.6% in the 2nd quarter. BlackRock Inc. now owns 8,891,430 shares of the basic materials company’s stock valued at $958,494,000 after acquiring an additional 54,291 shares during the period. Cerebellum GP LLC bought a new stake in Celanese in the 3rd quarter valued at about $129,000. Crossmark Global Holdings Inc. raised its stake in Celanese by 15.8% in the 3rd quarter. Crossmark Global Holdings Inc. now owns 6,793 shares of the basic materials company’s stock valued at $831,000 after acquiring an additional 928 shares during the period. Finally, Winmill & CO. Inc. bought a new stake in Celanese in the 3rd quarter valued at about $2,935,000. Institutional investors own 99.04% of the company’s stock.
NYSE:CE traded down $1.31 during trading hours on Friday, hitting $109.19. 250,176 shares of the company traded hands, compared to its average volume of 873,989. The company has a quick ratio of 0.98, a current ratio of 1.58 and a debt-to-equity ratio of 1.24. The firm’s 50-day simple moving average is $115.07 and its 200-day simple moving average is $118.44. Celanese has a one year low of $94.73 and a one year high of $128.88. The company has a market cap of $13.00 billion, a PE ratio of 16.10, a PEG ratio of 1.14 and a beta of 1.33.
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Tuesday, February 18th will be paid a dividend of $0.62 per share. This represents a $2.48 dividend on an annualized basis and a dividend yield of 2.27%. The ex-dividend date of this dividend is Friday, February 14th. Celanese’s payout ratio is 26.02%.
Celanese Company Profile
Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through Engineered Materials, Acetate Tow, and Acetyl Chain segments. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.
Read More: What is a portfolio manager?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Celanese Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celanese and related companies with MarketBeat.com's FREE daily email newsletter.